Gail Butensky’s photographs of alternative and punk rockers, now on show at I.C.P., find poignancy in the scene’s dissonance.

Nick Medina exclusively released to PEOPLE a look at the cover of his latest horror novel, 'The Whistler,' as well as a brief ...

Winrevair generated $200M Get the Real Story Behind Every Major Earnings Report Merck reported adjusted EPS of $1.72, up from $0.03 a year ago and beating the consensus of $1.62. Lower charges for ...

I just had this fantasy of doing something from a bird's eye view of an 18th century English village," says Libertine founder ...

Speaking on today's call will be Rob Davis, chairman and chief executive officer; Caroline Litchfield, chief financial officer; and Dr. Dean Li, president of Merck Research Labs. Before we get ...

and that’s Nick being Nick. I think most fighters would probably get their request, if they’re on the active roster, and they would probably think it’s probably not a great thing for me to do.

Merck’s stock tumbled 8% early Tuesday to lead S&P 500 decliners in the premarket, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected ...

In a report released on January 30, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target of $118.00. Leverage the power ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... He added: “Finally, on Friday, we get the Labor Department's non-farm payroll and right now the Fed is concerned ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

In our first episode back after the Oscar nominations, we chat with 'Nickel Boys' filmmaker RaMell Ross and costume designer ...

Get top local stories in San Diego delivered to you every morning. Sign up for NBC San Diego's News Headlines newsletter. Sales of the shot will likely be critical to Merck's efforts to offset ...